|
pubmed:abstractText |
Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-1) drug resistance mutations may adversely affect response to antiretroviral treatment (ART), but evidence regarding the effects of such mutations on the effectiveness of first-line ART is conflicting.
|
|
pubmed:affiliation |
Section of Retroviral Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts 02139, USA. jli22@partners.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Review,
Research Support, Non-U.S. Gov't,
Meta-Analysis,
Research Support, N.I.H., Extramural
|
